I've been in this company for over a year now so I
Post# of 15624
(Total Views: 425)
Posted On: 01/19/2018 5:22:49 PM
I've been in this company for over a year now so I'd think that would qualify me as an investor not a flipper. That being said, I'm pissed at the company. Their continued silence is bullshit.
1.) The company stated not some random poster its intent to cross-list. Six months later crickets...
2.) A company official stated results from the cream study would be out very soon... Again over six months later crickets...
3.) Last year's presentation was an epic failure. I know they're very smart people involved - Dr. Hirsch cannot go into the presentation and regurgitate the same information that's already on the investor powerpoint and think that will generate any additional investment / interest from those in attendance. They better have something big in the works to announce otherwise they will have pissed away another $100K.
4.) The last 8K stated update early 2018... of course that's vague so there's some leeway with that one, but tick, tock - most people would probably say the end of January is no longer early 2018.
5.) Dr. Hirsch cannot go into the presentation with the share price bleeding red. I contend anything below $1.00 is probably looked upon by the fund managers as get real - come back and see us again when you're ready to be taken seriously. I was really hoping for a $1.00 base going into the conference but that now appears to be a long shot.
6.) The new director showing on the WSJ page - it's very simple. Either we have a new director or not. Let's get the easy stuff done right for once.
I'm not in the camp of thinking my account will go to millionaire status overnight based on some grand reveal, but my expectations are to see continued progress... not constant decline like we experienced in 2017.
I appreciate your insights and optimism, but I also understand the frustrations many have with OWCP management. I can only hope those attending the conference will ask tough but fair questions of the OWCP team in attendance and don't let him get away with evasive answers. GLTA
1.) The company stated not some random poster its intent to cross-list. Six months later crickets...
2.) A company official stated results from the cream study would be out very soon... Again over six months later crickets...
3.) Last year's presentation was an epic failure. I know they're very smart people involved - Dr. Hirsch cannot go into the presentation and regurgitate the same information that's already on the investor powerpoint and think that will generate any additional investment / interest from those in attendance. They better have something big in the works to announce otherwise they will have pissed away another $100K.
4.) The last 8K stated update early 2018... of course that's vague so there's some leeway with that one, but tick, tock - most people would probably say the end of January is no longer early 2018.
5.) Dr. Hirsch cannot go into the presentation with the share price bleeding red. I contend anything below $1.00 is probably looked upon by the fund managers as get real - come back and see us again when you're ready to be taken seriously. I was really hoping for a $1.00 base going into the conference but that now appears to be a long shot.
6.) The new director showing on the WSJ page - it's very simple. Either we have a new director or not. Let's get the easy stuff done right for once.
I'm not in the camp of thinking my account will go to millionaire status overnight based on some grand reveal, but my expectations are to see continued progress... not constant decline like we experienced in 2017.
I appreciate your insights and optimism, but I also understand the frustrations many have with OWCP management. I can only hope those attending the conference will ask tough but fair questions of the OWCP team in attendance and don't let him get away with evasive answers. GLTA
(7)
(0)OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links
Scroll down for more posts ▼